---
title: "Johnson & Johnson Bets On Ottava To Challenge Intuitive Surgical In Robotic Surgery"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298760848.md"
description: "Johnson & Johnson is entering the robotic surgery market with its FDA-approved system, Ottava, aiming to challenge Intuitive Surgical. The device features a smaller footprint and has generated $5.16 billion in revenue for J&J's surgery unit in the first half of the year. Hani Abouhalka stated the goal is to become a leader in surgical robotics. Market projections indicate significant growth in both U.S. and global surgical robotics markets through 2035."
datetime: "2026-09-11T18:31:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298760848.md)
  - [en](https://longbridge.com/en/news/298760848.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298760848.md)
generator: "portal-rs"
---

# Johnson & Johnson Bets On Ottava To Challenge Intuitive Surgical In Robotic Surgery

According to CNBC, Johnson & Johnson is pushing into the robotic surgery market with Ottava, which received Food and Drug Administration approval this summer for use in multiple general surgery procedures. The company said the system’s smaller footprint and design features could help it win over surgeons and hospitals, while its surgery business generated $5.16 billion in revenue in the first six months of the year, up 4.3% from a year earlier. Hani Abouhalka, head of J&J’s surgery and robotics unit, said the company aims to become a leader in surgical robotics. Precedence Research projects the U.S. surgical robotics market will grow from about $4.4 billion in 2025 to $18.75 billion by 2035, while the global market is expected to rise from $14.45 billion in 2026 to about $50.29 billion by 2035. Ottava is approved for 10 general surgery procedures, and J&J said it is pursuing additional approvals in Western Europe and Japan as part of its rollout.

### Related Stocks

- [ISRG.US](https://longbridge.com/en/quote/ISRG.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [ISUL.US](https://longbridge.com/en/quote/ISUL.US.md)

## Related News & Research

- [Johnson & Johnson Targets Double-Digit Growth as STELARA Faces Biosimilar Competition](https://longbridge.com/en/news/298947604.md)
- [NEOS Investment Management LLC Buys 38,043 Shares of Johnson & Johnson $JNJ](https://longbridge.com/en/news/298824702.md)
- [Burford Brothers Inc. Decreases Stake in Johnson & Johnson $JNJ](https://longbridge.com/en/news/298797379.md)
- [Trajan Wealth LLC Has $10.13 Million Stake in Johnson & Johnson $JNJ](https://longbridge.com/en/news/298127700.md)
- [Health Rounds: New dye for MRI exams detects lung cancer earlier](https://longbridge.com/en/news/299086610.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**